The St. Jude Children’s Research Hospital Medication-Use Safety and Policy Residency is a 12-month ASHP-accredited PGY2 residency program that provides advanced training in medication safety and medication-use policy. The complex and high-risk nature of treatment provided at St. Jude provides a unique learning environment for patient safety and medication policy that can be applied later to any health care setting.
The resident will gain experience in medication error and adverse drug event reporting processes, lead medication safety assessment and improvement efforts to prevent future events and work to maximize the patient safety benefits of the electronic health record. Emphasis will be placed on leading and coordinating Cause Analyses, managing a medication use safety team/committee, and participating in methods to improve event detection and event reporting. The resident will also participate in both administrative and patient care aspects of the St. Jude medication-use process. Other activities include coordination of a pharmacy and therapeutics committee, guideline and policy development, regulatory readiness, completion of medication-use evaluations and audits, formulary management and adverse drug reaction analysis.
Along with medication-safety and policy experiences, the resident will acquire experience in teaching through lectures and precepting pharmacy students. The resident will be expected to complete a major project focused on medication safety or policy. Experiences during the residency will enable the resident to seek a career focused on medication safety or medication-use policy.
Program Structure
Rotations | Length of rotation | Sequence |
---|---|---|
Required Rotations | ||
Orientation | 1 month | July |
Clinical Oncology | 3 weeks | Fall |
Education and Presentations | Longitudinal | Begins in August and continues throughout the residency year |
Informatics and Precepting | Longitudinal | Begins in August and continues throughout the residency year |
Major Project | Longitudinal | Begins in July and continues throughout the residency year |
Medication-Use Policy | Longitudinal | Begins in August and continues throughout the residency year |
Medication Safety | Longitudinal | Begins in August and continues throughout the residency year |
Professionalism and Leadership | Longitudinal | Begins in August and continues throughout the residency year |
Elective | 1 month | Spring – choices include clinical rotations, pharmacogenomics, Pharmaceutical Investigational Services, outside elective rotation, etc. |
How to Apply
Qualified candidates are strongly encouraged to interview with St. Jude staff at the Professional Placement Service (PPS/CareerPharm) at the ASHP Midyear Clinical Meeting.
To apply, complete the following materials within PhORCAS:
- Official school transcript(s)
- Letter of intent
- Three (3) letters of reference
Other requirements include:
- Doctor of Pharmacy degree, successful completion of an ASHP-accredited PGY1 Residency, and eligibility for licensure to practice pharmacy in the state of Tennessee
- Completion of an onsite or virtual interview
Application deadline: January 10, 2025 by 11:59 p.m. CST
Submit residency application materials within PhORCAS to the PGY2 Residency Program Director listed below:
Number of Positions
One
Start Date
July 1
Program Director
Jennifer Robertson, PharmD, BCPS, FASHP
Mail Stop 150
Phone: (901) 595-6276
jennifer.robertson@stjude.org